Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.

Consensus $7.86. The company said, “The company raised its fiscal 2025 guidance range for non-GAAP diluted earnings per share attributable to ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Citi analyst Daniel Grosslight increased the price target for Cardinal Health (NYSE:CAH) shares to $130 from the previous $129, while keeping a Neutral rating on the stock. The adjustment follows ...

Wells Fargo raised the firm’s price target on Cardinal Health (CAH) to $135 from $127 and keeps an Equal Weight rating on the shares following ...

Thursday night at home, the Cardinal O’Hara Lady Hawks (No. 1 in The News' large schools poll) defeated the St Mary's Lancers ...

In a battle between the two top teams in the North Bay and a rematch of last year’s Northern California Division 3 semifinal ...

Cardinal Health, Inc. operates as a healthcare ... Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply ...

Cardinal Ethanol, LLC engages in production and sale of fuel-grade ethanol, distiller grains, corn oil, and raw carbon dioxide in the continental United States. The company’s ethanol is used as ...

CHAPEL HILL, North Carolina — Duke graduate transfer Jaylen Blakes hit a short jumper with 1.5 seconds left to lift Stanford ...

Jan 14 (Reuters) - Cardinal Health (CAH.N), opens new tab said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily driven by strong demand for ...